Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 30 Medical Device VC Funds in Finland

Last updated: Apr 2024 A list of 30 VC funds that invest in Medical device startups based in Finland. We rank investors based on the number of investments they made in Medical device companies from Finland. We update this investor list every month.

Top 30 Medical Device VC Funds in Finland

Investor	Medical Device Finland investments
Lifeline Ventures	6
Butterfly Ventures	4
Innovestor	4
Tesi	4
Finnvera Venture Capital	3
Voima Ventures	3
Icebreaker.vc	3
EQT Life Sciences	2
Nostetta Ventures	2
Cor Group	2
Business Finland	2
Inventure	2
Capricorn Partners	2
HealthCap	2
Redstone	2
VTT Ventures	2
Visionplus	1
Nidoco	1
Metsola Ventures	1
HTGF \| High-Tech Gruenderfonds	1
Sitra	1
Noaber	1
Gerresheimer Glas	1
MVM Life Science Partners	1
Flashpoint	1
Restone Capital	1
Nina Capital	1
3M New Ventures	1
Inveni Capital	1
Italian Angels for Growth	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Funding Round
Finland, United States, United Kingdom

Portfolio highlights

Mjuk — Marketplace for pre-owned, unique design furniture
Risk Ledger — Risk Ledger ensures your supply chain security by providing tools to run and respond to cyber security-led, third-party risk management programmes at scale.
Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.

Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.

Investment focus

Health Care, Software, Information Technology
Seed, Funding Round, Pre-Seed
Finland, Sweden, Norway

Portfolio highlights

RiACT — Software for robots. Real-time development platform for creators and users of flexible robot applications.
Embedl AB — Efficient Deep Learning by Deep Learning model optimization
EmbeDL — Efficient Deep Learning for Embedded Systems

Welcome to Innovestor! We are a Finnish investment company focusing on venture capital, corporate venturing services, and real estate.

Investment focus

Health Care, Software, Manufacturing
Seed, Funding Round, Series A
Finland, Denmark, Sweden

Portfolio highlights

Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
Kausal — Kausal helps cities turn their climate goals into action through a digital platform that enables smarter collaboration around key data.
Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.

Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570

Investment focus

Software, Manufacturing, Health Care
Funding Round, Series A, Series B
Finland, United States, Argentina

Portfolio highlights

Measurlabs — We provide testing services for any material, product, or chemical, helping product developers and quality managers get the information they need about their products.
Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Carbo Culture — We are a project developer with proprietary climate technology. We are building a rapidly scalable biochar carbon removal solution.

Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.

Investment focus

Software, Health Care, Information Technology
Seed, Funding Round, Series A
Finland, United States, Switzerland

Portfolio highlights

Enfuce — Enfuce is a cloud-based financial services provider that specializes in card issuing and payment processing services. It helps banks, fintech, and financial institutions become and remain fully PSD2 compliant, and helps them give third-party service providers access to digital accounts.The company was founded in 2016 and is headquartered inEspoo, Finland.
Nordcloud — Nordcloud is a European leader in public cloud infrastructure solutions and cloud-native application services. Since 2011 we have completed more than 500 deployments to help our enterprise customers gain the maximum benefits of the cloud, including security, agility, scalability and overall cost-savings.
Aurealis Pharma — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Investment focus

Biotechnology, Software, Health Care
Seed, Pre-Seed, Funding Round
Finland, Sweden, Norway

Portfolio highlights

n-Ink — n-ink provides n-type ink formulations compatible with solution-deposition processes for Printed Electronics, Internet of Things and Bioelectronics.
Kuva Space — Kuva Space improves life on Earth through daily, space-borne hyperspectral imaging and AI. We offer Earth observation solutions for more sustainable business.
The Human Touch Robotics — Automating online grocery and food related goods picking with single-item picking robots, through adaptive gripping and AI vision system.

Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.

Investment focus

Software, Information Technology, Artificial Intelligence
Pre-Seed, Seed, Series A
Finland, Estonia, Sweden

Portfolio highlights

Zymego — Zymego develops solutions that relieve healthcare workers of administrative work while improving patient access to healthcare.
Fixably — Fixably is the repair management solution to seamlessly connect all users, from the end customer to the technician, and all repair systems within your service business.
Tab — Tab is the API-first company that enables smart receipts to arrive straight to your mobile bank app, all linked to your payment card. We help merchants deliver a seamless checkout experience and to unlock new avenues for post-sale engagement, banks to offer better user experiences & reducing customer support costs and consumers can wave goodbyeto lost receipts, tedious expense reporting processes and a more engaging banking experience.

EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, The Netherlands, Switzerland

Portfolio highlights

Onera Health — Introduction to Onera sleep diagnostics and monitoring solutions
Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

Nostetta Ventures is a venture capital company investing in growth companies mainly in the North Savo region.

Investment focus

Health Care, Medical Device
Seed
Finland

Portfolio highlights

Marginum — Pioneering the next-generation quantitative surgical techniques.

Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.

Investment focus

Health Care, Medical, Biotechnology
Seed, Pre-Seed, Series A
Finland

Portfolio highlights

Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
Nightingale Health — Driving the shift from reactive to preventative care with innovative solutions that enable early detection and proactive management of health risks.

Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.

Investment focus

Software, SaaS, Information Technology
Seed, Grant, Funding Round
Finland, United States, United Kingdom

Portfolio highlights

Teamspective — Teamspective's SaaS solution helps companies create culture of performance and wellbeing in their organization through - Actionable and real-time visibility to employee wellbeing and effectiveness of teams' collaboration - Replacing heavy 360 feedbacks with timely collection of high quality feedback that activates personal development -Modernizing performance evaluations with a process that takes only minutes per employee and eliminates rater bias - Understanding organization's dynamics through ONA surveys that are 10x faster and cheaper than consulting-driven versionsTeamspective's customers have 2x higher amount of employees satisfied with the feedback they receive.
Supersight — 100% privacy preserving mobile app for people counting, revolutionising real world business process automation. A Finnish high-tech product is most efficient method on the market for counting the number of people in a space with our AI technology, ensuring complete privacy and a productive environment for all. Customers in Finland and France.
Linio Biotech Ltd — Science by nature, Inspired by biology, driven by curiosity. We redefine skin regeneration.

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Investment focus

Software, Information Technology, Mobile
Seed, Series A, Series B
Finland, Sweden, Denmark

Portfolio highlights

Leya AI — Feel and sound like an English native in 3 months
UltiHash — Data powers breakthroughs. UltiHash is the storage foundation to accelerate them: blazing fast, highly efficient, and built for sustainable long-term growth.
Reveel — Say goodbye to paper maps, brochures, and outdated audio guides. Reveel offers digital solutions for destinations such as UNESCO sites, sights, museums, cities, hotels and parks, taking the visitor experience to the next level. Become part of the smart destination movement, enhance the visitor experience, and discover the future of travel.

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Investment focus

Biotechnology, Health Care, Software
Funding Round, Series B, Series A
Belgium, United States, The Netherlands

Portfolio highlights

Chainels — The tenant experience app for every property in your portfolio. Save time, gain insights and collaborate with your tenants all in one place.
VoxelSensors — Novel sensor architecture designed for low latency and low power 3D perception.
Electric Hydrogen — Electric Hydrogen designs and builds low-cost, high-efficiency green hydrogen systems to economically decarbonize industrial sectors like ammonia and steel

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United States, Sweden, France

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.

The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Funding Round
Germany, Finland, Switzerland

Portfolio highlights

Hiboo — Hiboo is data infrastructure platform that helps you collect, control, and visualise your equipment data.
Chipmetrics — Test chip, test elements and test wafer business concept builder for advanced materials and microelectronics manufacturing. Expert in thin film conformality characterization. Mission is to accelerate applications of conformal 3D thin films. Main product line: PillarHall test chips.
Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.

VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?

Investment focus

Manufacturing, Biotechnology, 3D Technology
Seed, Funding Round, Series A
Finland

Portfolio highlights

Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.

WE HELP YOU TO GROW FASTER!

Investment focus

Software, Information Technology, Internet
Seed, Funding Round, Series A
Finland, United States, United Kingdom

Portfolio highlights

Pebble — Pebble is a electric vehicle manufacturing startup.
Transfluent — Professional translations for all business needs. Fast. Easy.
BetterDoctor — BetterDoctor helps validate and deliver accurate provider data to health plans, health systems, and hundreds of other companies via its API — from startups to publicly traded ones. This ultimately helps achieve the mission of helping consumers find the healthcare they need.Today, BetterDoctor's data platform and APIs power 9 health plans,350 companies, 1,500 developers, helping millions of people find the right doctor each month. Health Plans BetterDoctor uses multi-modal outreach to drive providers to attest their information on BetterDoctor's online portal. API PartnersBetterDoctor brings transparency to doctor data. Their real-time platform, master database and API services enable everyone to add doctor data to their systems, websites and applications. Today, BetterDoctor API and data tools power health insurance companies, healthcare startups and doctor search tools. https://betterdoctor.com/developers

Nidoco AB is a Swedish investment company whose strategy is to create long-term value through active ownership of public and private companies.

Investment focus

Health Care, Software, Artificial Intelligence
Seed, Funding Round, Series B
Finland, Sweden, Estonia

Portfolio highlights

Spiral — Easily make a difference every day
Voltan Energy — Voltan Energy is a sustainable and affordable local heating and cooling solutions.
Skeleton Technologies — Skeleton Technologies is the global leader in ultracapacitor & supercapacitor energy storage and helps companies in automotive, transportation, grid, and industry to save energy.

Metsola Ventures

Investment focus

Medical, mHealth, Health Care
Series A
Finland

Portfolio highlights

Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
Synoste Oy — Patient friendly and innovative solutions for correcting skeletal deformations.

The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.

Investment focus

Software, Information Technology, Biotechnology
Seed, Series A, Funding Round
Germany, Switzerland, United States

Portfolio highlights

Graswald — Graswald engages in the creation of natural and digital 3D worlds for the entertainment industry.
CustomSurg — RETHINKING TRAUMA SURGERY At CustomSurg we are changing the treatment of complex bone fractures from a subjective to an objective approach, through personalized solutions.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.

Investment focus

Health Care, Biotechnology, Therapeutics
Funding Round, Series A, Series C
Finland, The Netherlands

Portfolio highlights

Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
SET Ventures — Venture capital firm focused broadly on innovative energy generation, distribution storage and efficiency.

Noaber Ventures invests in initiatives that bring social transformations using information technology.

Investment focus

Health Care, Medical, Fitness
Seed, Series A, Funding Round
The Netherlands, Israel, Sweden

Portfolio highlights

Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Alba Health — Discover your baby's gut health & microbiome for the best start in life.

Gerresheimer is a leading global partner to the pharma and healthcare industry. With our specialty glass and plastic products, we contribute to health and well-being. We have worldwide operations and about 10,000 employees manufacture our products in local markets, close to our customers. With our plants in Europe, North America, South America, andAsia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, refillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Investment focus

Health Care, Medical Device
Seed
Finland

Portfolio highlights

Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.

MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.

Investment focus

Health Care, Biotechnology, Medical
Funding Round, Series B, Series C
United States, United Kingdom, Switzerland

Portfolio highlights

Icotec — Icotec develops and produces carbon fiber reinforced plastic implants for spine surgeries and accident treatments.
Gynesonics — Gynesonics is a women’s healthcare company focused on the development of advanced incision-free solutions for the treatment of uterine conditions. Gynesonics serves customers worldwide. It was founded in 2005 and is headquartered in Redwood City, California.
Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.

Flashpoint is an international technology investment firm that manages venture capital, secondary buy-out and venture debt funds.

Investment focus

Software, SaaS, Machine Learning
Series A, Seed, Funding Round
United States, Israel, United Kingdom

Portfolio highlights

Algori — Improving FMCG growth with the fastest and most granular insights from 45,000 shoppers in Spain
Hotelmize — Our Big Data Solutions for the booking Industry identify and take advantage of booking price volatility, automatically increasing your profitability.
Welcome Pickups — Book a trusted local driver to pick you up and introduce you to your next destination, pre-order travel essentials.

Restone Capital is an investment management organization focusing on smart energy, smart manufacturing and other fields.

Investment focus

Energy, Energy Efficiency, Energy Management
Series B
China

Portfolio highlights

Enyipu — NXP is a global provider of solar micro-inverters, rapid shutdowns, and micro-grid smart energy system solutions.
Marginum — Pioneering the next-generation quantitative surgical techniques.
Huamei new materials — Huamei new materials manufactures reaction sintered silicon carbide products, focusing on high-tech silicon carbide ceramics. Widely used in JG, aerospace, electronic semiconductors, liquid crystals, new energy vehicles, photovoltaic solar energy, metallurgy, chemical industry, machinery, papermaking, medicine, and almost every other industrialfield that requires high temperature resistance, thermal shock resistance, wear resistance, and corrosion resistance.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Software
Seed, Pre-Seed, Series A
United States, United Kingdom, Austria

Portfolio highlights

Ryver — We provide software to generate synthetic medical images and assess their privacy as well as quality
CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of

3M New Ventures was created to strengthen 3M's position at the leading edge of global innovation by complementing 3M's holistic innovation strategy with a focus on disruptive, early stage innovations outside of the company's existing portfolio. 3M New Ventures identifies and invests in the most promising new-to-3M technologies,services and business models with long term strategic relevance to 3M.

Investment focus

Software, Medical Device, Electronics
Series A, Series B, Funding Round
United States, Germany, Israel

Portfolio highlights

Flair — Smart climate control in every room. Wireless smart thermostats and Smart Vents for Central Heating & AC, Mini Splits, Window ACs, Nest, Ecobee, and more
Metalenz — Metasurface optics to enable the next generation of sensing. Unparalleled control, performance, and information from a single flat lens made in the semiconductor foundry.
GrayMatter Robotics — GrayMatter Robotics creates solutions to assist humans in tedious and ergonomically challenging tasks. It develops robotic brains for industrial robots designed to allow them to transform into smart assistants for high-mix low-volume manufacturing applications. It makes AI-brains for robots to make them smart, easy to use and rapidly deployable forcomplex operations, enabling users to improve their quality of life by leveraging robotics and artificial intelligence.The company was founded in 2020 and is based in Los Angeles, California.

Inveni Capital is a venture capital management company focused on investments in early to growth stage life sciences companies.

Investment focus

Medical, Health Care, Biotechnology
Funding Round
Finland, United Kingdom

Portfolio highlights

BioSilta — BioSilta Ltd. is a privately-held company that utilizes its unique, proprietary EnBase® technology platform to develop innovative, reagent-based EnPresso® growth systems. When compared to conventional growth media, EnPresso growth systems significantly increase the yield of high quality biomolecules from microbial cultures.
Onbone — Onbone Ltd is a Finnish innovative company working on the field of medical technology. The company develops and markets innovative and user-friendly Woodcast products for orthopaedic and traumatology use. Onbone Ltd has eleven employees and the products are sold in Finland, Germany, Sweden, Holland and Great Britain.

IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.

Investment focus

Software, E-Commerce, Health Care
Seed, Angel, Series A
Italy, United States, United Kingdom

Portfolio highlights

ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
Viceversa — Viceversa provides capital to European digital businesses to support companies in sustainable and ethical growth. The company was founded in 2021 and has locations in Milan and Dublin.
Clearbox AI — Benefit from Synthetic Data to unlock your AI projects, overcome privacy issues and improve the utility of your data.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate